Subjects

Nature 513, 436–439 (2014); doi:10.1038/nature13540

This Letter should have declared the following competing financial interests: “The fibroblast growth factor (FGF) molecules and related methods of use reported in this study are covered in the following published patent applications and counterparts that derive priority: (1) PCT/US2011/032848, held by R.M.E., M.D., J.W.J., and J.M.S. (handled by Salk OTD); (2) PCT/US2013/044589, held by M.M., R.G., R.M.E., M.D. and J.M.S. (handled by NYU Office of Industrial Liaison/Technology Transfer); (3) PCT/US2013/044594, held by M.M., R.G., R.M.E., M.D. and J.M.S. (handled by NYU Office of Industrial Liaison/Technology Transfer); and (4) PCT/US2013/044592, held by M.M. and R.G. (handled by NYU Office of Industrial Liaison/Technology Transfer).”.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nature14304

Authors

  1. Search for Jae Myoung Suh in:

  2. Search for Johan W. Jonker in:

  3. Search for Maryam Ahmadian in:

  4. Search for Regina Goetz in:

  5. Search for Denise Lackey in:

  6. Search for Olivia Osborn in:

  7. Search for Zhifeng Huang in:

  8. Search for Weilin Liu in:

  9. Search for Eiji Yoshihara in:

  10. Search for Theo H. van Dijk in:

  11. Search for Rick Havinga in:

  12. Search for Weiwei Fan in:

  13. Search for Yun-Qiang Yin in:

  14. Search for Ruth T. Yu in:

  15. Search for Christopher Liddle in:

  16. Search for Annette R. Atkins in:

  17. Search for Jerrold M. Olefsky in:

  18. Search for Moosa Mohammadi in:

  19. Search for Michael Downes in:

  20. Search for Ronald M. Evans in:

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.